A New CRISPR-Engineered Cancer Model to Test Therapeutics

News   Oct 06, 2017 | Original story from Broad Institute

 
A New CRISPR-Engineered Cancer Model to Test Therapeutics

Credit : Susanna M. Hamilton, Broad Communications

 
 
 

RELATED ARTICLES

Biometric System Measures Brainwaves, Creates Brain Password

News

The “brain password” could have implications in banking, law enforcement, airport security and other areas.

READ MORE

Cryo-EM Reveals Interaction Between Major Drug Targets

News

For the first time, scientists have visualized the interaction between two critical components of the body's vast cellular communication network, a discovery that could lead to more effective medications with fewer side effects for conditions ranging from migraine to cancer.

READ MORE

The Friedrich Schiller University Jena Partners with ACD/Labs to Advance its Analytical Data Management Strategy

News

Implementation of ACD/Spectrus as an analytical data management system helps researchers and students streamline NMR and MS data processing, interpretation, collaboration, and training.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Biopharma Cancer Research Drug Discovery Informatics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE
 

We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy